Prognostic value of high-sensitivity cardiac troponin I after isolated non-CABG cardiac surgery

Felix Rudolph1,2, Marcus-André Deutsch3, Kai Peter Friedrichs4

  • 1Department of General and Interventional Cardiology/Angiology, Heart and Diabetes Center NRW, Ruhr University Bochum, Medical Faculty OWL (University of Bielefeld), Bad Oeynhausen, Germany.

Insights

Peak postoperative high-sensitivity cardiac troponin I (hs-cTnI) levels predict mortality after heart valve or thoracic aortic surgery. However, their poor predictive performance indicates a need for surgery-specific thresholds for better risk assessment.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Biomarkers
  • Prognostic Indicators

Background:

  • High-sensitivity cardiac troponin I (hs-cTnI) is a key biomarker in acute coronary syndromes.
  • Its prognostic role in patients undergoing cardiac valvular (CV) or thoracic aortic (TA) surgery without coronary artery bypass grafting (CABG) remains to be fully elucidated.

Purpose of the Study:

  • To investigate the prognostic value of peak postoperative hs-cTnI levels.
  • To assess the association between hs-cTnI and short-term (30-day) and long-term all-cause mortality in patients undergoing isolated CV or TA surgery.

Main Methods:

  • Prospective, single-center registry analysis of 4232 adult patients undergoing elective, isolated CV or TA surgery.
  • Hs-cTnI levels measured preoperatively and up to 48 hours postoperatively.
  • Cox proportional hazards models with regression splines used to assess associations with mortality, adjusted for EuroSCORE II.

Main Results:

  • Peak hs-cTnI thresholds of 282×ULN and 194×ULN were associated with increased long-term and 30-day mortality risk, respectively.
  • Predictive performance was limited, with Area Under the Curve (AUC) values of 0.56 for long-term and 0.55 for 30-day mortality.
  • Sex-specific thresholds showed slightly improved AUCs (0.58 and 0.57, respectively), but overall discrimination remained poor.

Conclusions:

  • Peak hs-cTnI levels are independently associated with adverse outcomes after CV or TA surgery without CABG.
  • Current hs-cTnI thresholds offer poor risk discrimination in this patient population.
  • Development of surgery-specific hs-cTnI thresholds is necessary for improved perioperative risk stratification.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
782
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
785
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.0K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
214
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
638